CRWM
MRNA icon

Castle Rock Wealth Management’s Moderna MRNA Stock Holding History

Castle Rock Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,458
Closed -$771K – 233
2023
Q3 		$771K Buy
7,458
+1,587
+27% +$177K 0.26% 100
2023
Q2 		$725K Buy
5,871
+2,704
+85% +$361K 0.25% 99
2023
Q1 		$424K Sell
3,167
-12
-0.4% -$1.98K 0.15% 137
2022
Q4 		$614K Buy
+3,179
New +$520K 0.27% 103
2021
Q4 		– Sell
-2,533
Closed -$620K – 269
2021
Q3 		$620K Buy
2,533
+1,825
+258% +$673K 0.21% 133
2021
Q2 		$323K Buy
+708
New +$127K 0.12% 197

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Castle Rock Wealth Management's MRNA Position: Q4 2023 in Review

Castle Rock Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 7,458 shares — an estimated $771K sold.

Castle Rock Wealth Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $771K in Q3 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Castle Rock Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Castle Rock Wealth Management sold 7,458 Moderna shares in Q4 2023, an estimated $771K.
  • Castle Rock Wealth Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Castle Rock Wealth Management's Moderna position peaked at $771K in Q3 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Castle Rock Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.